Biogen Inc (WBO:BIIB)
€ 160.4 -1.45 (-0.9%) Market Cap: 23.36 Bil Enterprise Value: 27.94 Bil PE Ratio: 15.63 PB Ratio: 1.54 GF Score: 69/100

Q2 2019 Biogen Inc Earnings Call Transcript

Jul 23, 2019 / 12:00PM GMT
Release Date Price: €217.24 (+4.61%)
Operator

Good morning. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Second Quarter 2019 Financial Results and Business Update. (Operator Instructions) Thank you.

I would now like to turn the conference over to Biogen's CEO, Michel Vounatsos. You may begin your conference.

Michel Vounatsos;Joe Mara
Biogen Inc. - CEO & Director;Biogen Inc.

Thank you. Good morning, everyone, and thank you for joining us. I would like to start by thanking Matt Calistri for nearly 4 years he spent leading our Investor Relations program. We wish him the very best in his next endeavor. I would like to welcome Joe Mara, our new Vice President and Head of Investor Relations, who is a talented and energized finance and business leader with over 12 years of experience at Biogen across a number of functions. I'm confident that Joe will prove to be a valuable resource for the investment community and I look forward to all of you getting to know Joe. Joe, the floor is yours.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot